NEURAXIS INC
NRXS·64134X201·US·Common Stock·Healthcare - Biotechnology-13D/G
NRXS (NEURAXIS INC) is held by 14 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.7M), GEODE CAPITAL MANAGEMENT, LLC ($689,248), MARSHALL WACE, LLP ($582,343). Net institutional sentiment: Mixed.
14
Holders
Avg rating(2 Elite)
$5.4M
Total Value
64% (16)
Fund Consensus
9 buying - 5 selling
Who's Trading
ActivistBLBIGGER CAPITAL FUND L P6.6%May 1, 2026
InsiderAGAharon GilVest 222K shApr 28, 2026
InsiderAGAharon GilVest 12K shApr 28, 2026
InsiderCACarrico Brian AllenBuy $16KApr 1, 2026
InsiderCJCarrico Thomas JoesephBuy $1KApr 1, 2026
InsiderHRHenrichs Timothy RobertBuy $15KApr 1, 2026
InsiderAGAharon GilBuy $1.0MDec 23, 2025
ActivistBPBrian P. Hannasch12.0%Jul 2, 2025
InsiderMCMASIMO CORPSell $652KJul 1, 2025
InsiderMCMASIMO CORPSell $1.2MJul 1, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer